Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.
Parkinson, D R, Fisher, R I, Rayner, A A, Paietta, E, Margolin, K A, Weiss, G R, Mier, J W, Sznol, M, Gaynor, E R, Bar, M HVolume:
8
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1990.8.10.1630
Date:
October, 1990
File:
PDF, 581 KB
english, 1990